- Houten SM, Violante S, Ventura FV, Wanders RJA, The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders. ANNU REV PHYSIOL 2016;78:23-44 [PubMed]
- Vaz FM, Paulusma CC, Huidekoper H, de Ru M, Lim C, Koster J, Ho-Mok K, Bootsma AH, Groen AK, Schaap FG, Oude Elferink RPJ, Waterham HR, Wanders RJA, Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype. HEPATOLOGY 2015;61 (1):260-267 [PubMed]
- Bennett MJ, Rinaldo P, Wilcken B, Pass KA, Watson MS, Wanders RJA, Newborn screening for metabolic disorders: how are we doing, and where are we going?. CLIN CHEM 2012;58 (2):324-331 [PubMed]
- Wanders RJA, Komen J, Ferdinandusse S, Phytanic acid metabolism in health and disease. BBA-MOL CELL BIOL L 2011;1811 (9):498-507 [PubMed]
- van Roermund CWT, Visser WF, Ijlst L, Waterham HR, Wanders RJA, Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation. BBA-MOL CELL BIOL L 2011;1811 (3):148-152 [PubMed]
Ronald (R.J.A.) Wanders has studied Chemistry at the University of Amsterdam with a subspecialization in Biochemistry and subsequently did his PhD at the E.C. Slater Institute for Biochemical Research, University of Amsterdam (1977-1982) under the leadership of Prof. Dr. J.M. Tager. In 1983 Wanders joined the Laboratory Genetic Metabolic Diseases at the Academic Medical Center (AMC) of the University of Amsterdam (UvA) as postdoc with the objective to: (1.) perform research on Zellweger syndrome and other peroxisomal disorders, and (2.) set up an Enzymology Laboratory, capable of doing selective enzyme assays in patients suspected to suffer from certain inborn errors of metabolism (IEMs) including peroxisomal diseases, fatty acid oxidation disorders, amino oxidation defects, among others. He is full professor in Clinical Enzymology of IEMs since 1996, and is Head of the Laboratory Genetic Metabolic Diseases since 2003. Wanders has been promotor of 34 completed PhD thesis works, and copromotor of ... PhD thesis works and has published more than 936 papers in peer-reviewed journals. Wanders is member of several Editorial Boards of scientific journals (Human Mutation (2006-2011), Biochimica Biophysica Acta, Molecular Basis of Diseases, Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, Journal of Biological Chemistry, World Journal of Biological Chemistry), member of different medical Advisory Boards (Prinses Beatrix Fonds (PBF), European Leukodystrophy Association (ELA), Barth Syndrome Foundation (BSF), and member of different national and international Selection Committees, including NWO-VICI (2007-2011). Wanders has received several awards including the IFCC 2011 SDistinguished Award for Laboratory Medicine and Patient Care.
'71-76: M.SC Master of Sciences Chemistry with specialization in Biochemistry, University of Amsterdam.
'77-'82: PhD-student at the Department of Biochemistry, E.C. Slater Institute for Biomedical Research. Title Thesis: 'Quantitative studies on the control of flux'. (PhD Professor/Promotor: Prof. J.M. Tager).
'83-'88: Post-doc. fellow at the Laboratory of Genetic Metabolic Diseases, Departments of Pediatrics and Clinical Chemistry, Academic Medical Center, University of Amsterdam.
'88-present: Staff member, Department of Pediatrics, Academic Medical Center, University of Amsterdam.
'88-'96: Associate Professor and Head of the section Enzymology of Inherited Metabolic Diseases, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam.
'96-present: Professor of Clinical Enzymology & Inherited Metabolic Diseases, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam.
'03-present: Head of the laboratory of Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam.
Biochemistry & Enzymology of Metabolic Disorders
Peroxisomes were long thought to play only a minimal role in human physiology until the early 1980s when studies in a rare lethal autosomal recessive disorder called Zellweger syndrome revealed that peroxisomes are in fact indispensible organelles playing a key role in human physiology. Indeed, peroxisomes are now known to catalyze multiple metabolic functions including: (1.) the beta-oxidation of certain fatty acids notably very long-chain fatty acids; (2.) the synthesis of etherphospholipids (plasmalogens); (3.) the alpha-oxidation of 3-methyl branched chain fatty acids including phytanic acid, and (4.) the detoxification of glyoxylate. Subsequent to the discovery of Zellweger syndrome as the prototype peroxisomal disorders many additional peroxisomal diseases have been identified. .......
Prof. dr. R.J.A. Wanders
Dr. S. Ferdinandusse PhD
Prof. dr. R.H. Houtkooper
Dr. S. Kemp
Dr. A.B.P. van Kuilenburg
Dr. W. Kulik PhD
Dr. C.W.T. van Roermund
Dr. F.M. Vaz PhD
Prof. dr. H.R. Waterham
Dr. M. van Weeghel MSc
Drs. C.E. van Engen MD
M. Molenaars MSc
I.R.N. Verly MD (Prinses Maxima centrum voor kinderoncologie)
H. te Brinke BSc
Ing. S. Denis
Ing. L. IJlst
Prof. dr. H.R. Waterham (Functional Genetics of Metabolic Diseases)
- Membership of Scientific Advisory Board, Prinses Beatrix Fonds
- Membership of advisory board / Consultant, NWO: Netherlands Organisation
- Other, NWO: Netherlands Organisation
- Membership of editorial board / Editorship, MOLECULAR GENETICS AND METABOLISM
- Membership of editorial board / Editorship, HUMAN MUTATION
- Membership of editorial board / Editorship, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Membership of editorial board / Editorship, JOURNAL OF BIOLOGICAL CHEMISTRY
- Membership of editorial board / Editorship, JOURNAL OF INHERITED METABOLIC DISEASE
- Leadiant Biosciences Limited
- Stichting Stofwisselkracht